Episoder
-
Has the fever broken for the high momentum stocks? Nvidia running out of steam this week, as some other high fliers also pull back. Is this just a bump in the road or the beginning of a summer slowdown? Plus Sarepta’s big surge. The biotech company getting expanded approval from the FDA for its muscular dystrophy drug. What the CEO says is next for the company.
Fast Money Disclaimer
-
Some of this year’s red hot stocks have seemed to hit a wall. Nvidia, Chipotle, Netflix… all taking a leg lower in today’s session. Is the pullback temporary? Or could there be more downside ahead. Plus Gilead’s big boost. Shares jumping after the biotech company’s latest trial results. What the data could mean in the fight against HIV.
Fast Money Disclaimer
-
Manglende episoder?
-
There’s a new biggest bull on Wall Street, as Evercore’s Julian Emanuel ups his year-end price target on the S&P by 25% to a whopping 6,000/ What’s going to drive those returns and how should you play the market? Plus Industrials have been struggling so far in 2024, but one top technician says these names are about to witness a turnaround. We go off the charts to get the details.
Fast Money Disclaimer
-
There’s a new biggest bull on Wall Street, as Evercore’s Julian Emanuel ups his year-end price target on the S&P by 25% to a whopping 6,000/ What’s going to drive those returns and how should you play the market? Plus Industrials have been struggling so far in 2024, but one top technician says these names are about to witness a turnaround. We go off the charts to get the details.
Fast Money Disclaimer
-
Apple and Netflix both having strong weeks as the stocks trade near record highs. What’s next for the names and what could their rise mean for the rest of the markets? Plus long-struggling Gilead getting a boost today on early results of its experimental obesity pill. Can it effectively compete with the likes of Eli Lilly and Novo Nordisk?
Fast Money Disclaimer
-
Tesla shareholders voting on CEO Elon Musk’s pay package. The billions that could come his way, and if the EV maker’s incorporation will stay in Delaware or head to the lone star state. Plus Media stocks in the red as the future of television and streaming continue to evolve. What the stock moves could be telling us about the media landscape.
Fast Money Disclaimer
-
Another pause out of Powell, as the Federal Reserve leaves rates unchanged, noting some progress on inflation. What the central bank is forecasting for rate cuts this year. Plus The rate decision’s impact on financial stocks. Why one top bank analyst says it could be a boost for the group.
Fast Money Disclaimer
-
Shares of Apple jumping to record highs just a day after falling flat on its new AI announcements. The turnaround for the tech titan, and what it means for the market. Plus The weight loss wars rage on… and we’re honing in on oral version of GLP-1’s. How one pharma stock is faring in the space, and how their results stack up against the competition.
Fast Money Disclaimer
-
Apple upping the AI wars with their latest announcement: Apple Intelligence. How the new tech titan’s new push into AI will stack up, and how they’re incorporating ChatGPT. Plus European elections skewing to the right, all while investors here at home await a key Fed decision. How it all will impact markets.
Fast Money Disclaimer
-
Rates surging after this morning’s stronger-than-expected jobs report. How the hot data is impacting the likelihood of a Fed rate cut. Plus Gamestop taking a big leg lower, as the company plans a big stock sale. What they could do with the money, and how Roaring Kitt’s livestream didn’t seem to help shares.
Fast Money Disclaimer
-
Veteran "Halftime" guest and investor Jim Lebenthal sat down with CNBC's Dominic Chu to discuss how the former nuclear engineer and U.S. Navy officer created a science-minded approach to fundamental analysis and value investing that has led to a decades-long career on Wall Street. Lebenthal goes into detail on how he uses different fundamental analytical tools, walking Pro subscribers through how he finds price-to-earnings growth ratios of stocks like Amazon and Nvidia. He also gives examples of how to incorporate tools from technical analysis to help augment his decision-making process, and fields stock-specific questions from Pro subscribers.
CNBC Pro Talks features one-on-one interviews with Wall Street’s top investors, smartest traders and rising stars. CNBC’s Dominic Chu finds out what makes them tick, what makes them money, and how you can follow in their footsteps. CNBC Pro Talks is a monthly interview series that’s part of CNBC’s premium subscription service, CNBC Pro. To hear the full Pro Talk interview—including specific stock picks and investment strategies—listeners can subscribe to [cnbc.com/protalks]. -
Commodities rising across the board, as oil, metals, and agricultural prices all climb. But as those all head higher, rates continue to fall. What the moves could be saying about the market. Plus Eli Lilly’s Alzheimer’s treatment raising some eyebrows at the FDA. What regulators are flagging, and how it could impact the future of the drug.
Fast Money Disclaimer
-
Listen to our traders take you behind the money...how to play the volatility...pops and drops and the movers you missed.
Fast Money Disclaimer
-
The traders lay out the one chart telling the real market story. How the levels and price action in these areas could detail where stocks head next. Plus One telehealth company launching a weight loss drug tracker, as the surge in popularity causes shortages. How they’re tipping the scales in the obesity drug wars.
Fast Money Disclaimer
-
Barrels, builders, and the big semi trade. Three areas of the market with major moves today. How you should play oil, homebuilders, and the chip stocks. Plus India and Mexico markets heading in very different directions as election results impact stocks. What the divergence means for your money.
Fast Money Disclaimer
-
May trading in the books, and after a tame inflation read this morning, investors are honing in on June trading. How to position, and where your money can get the best bang for its buck. Plus A crude reality for oil, as the commodity notches its worst month of the year. And with the latest OPEC meeting kicking off Sunday, will energy be able to turn things around?
Fast Money Disclaimer
-
Stocks tumbling as investors eye tomorrow’s key inflation read. But will the PCE data show the Fed’s finally getting on top of inflation. Plus… Foot Locker kicking higher after earnings. How the sneaker company is implementing their turnaround plan… and if this name can keep running.
Fast Money Disclaimer
-
Rates continue their climb higher, and besides a powerhouse move in Nvidia, stocks have been feeling the pain. Will the rising rate environment continue to be a headwind for companies? Plus… Retailers rising after results. Dicks Sporting Goods, Chewy, and Abercrombie & Fitch all soaring after reporting. But will those same rising rates put pressure on the consumer? Why a former retail exec says the shopper can handle it.
Fast Money Disclaimer
-
Is there more trouble brewing in the office real estate space? The shocking stat that could mean big problems for lenders, and why the government may need to get involved. Plus Insmed’s incredible day. The pharma stock surging as new drug trial results blow past expectations. What it could mean for the future of the company.
Fast Money Disclaimer
- Vis mere